Patients' beliefs about long-term glucocorticoid therapy and their association to treatment adherence;Le ressenti des patients vis-à-vis d'une corticothérapie orale prolongée influence l'adhérence déclarée à ce traitement

Revue de Medecine Interne

Volumn 33, Issue 6, 2012, Pages 300-304

  Zerah, L ^a   Arena, C ^b   Morin, A S ^c   Blanchon, T ^b   Cabane, J ^a,d   Fardet, L ^a,b,d  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSERM   (France)

^c HÔPITAL JEAN VERDIER   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

Adherence; Glucocorticoids; Medicine beliefs

Indexed keywords

GLUCOCORTICOID; PREDNISONE;

ADULT; AGE; ARTICLE; BELIEFS ABOUT MEDICINES QUESTIONNAIRE; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH BELIEF; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORISKY GREEN SCALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; TREATMENT DURATION;

ADULT; CROSS-SECTIONAL STUDIES; CULTURE; FEMALE; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAINTENANCE CHEMOTHERAPY; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PERCEPTION; QUESTIONNAIRES; TIME FACTORS;

EID: 84862157599     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2012.02.001     Document Type: Article

References (22)

1. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization, 2003 (site internet). Consultable sur [accès le 30 janvier 2011]. http://www.who.int/chp/knowledge/publications/adherence_%20full_report.pdf.
2. Butler J.A., Roderick P., Mullee M., Mason J.C., Peveler R.C. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 2004, 77:769-789.
3. Duran S., Savès M., Spire B., Cailleton V., Sobel A., Carrieri P., et al. Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy. AIDS 2001, 15:2441-2444.
4. Braithwaite R.S., Kozal M.J., Chang C.C., Roberts M.S., Fultz S.L., Goetz M.B., et al. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS 2007, 21:1579-1589.
5. Horne R., Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999, 47:555-567.
6. Daleboudt G.M., Broadbent E., McQueen F., Kaptein A.A. Intentional and unintentional treatment non-adherence in patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011, 63:342-350.
7. Neame R., Hammond A. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology (Oxford) 2005, 44:762-767.
8. Phatak H.M., Thomas J. Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Ann Pharmacother 2006, 40:1737-1742.
9. Arena C., Morin A.S., Blanchon T., Hanslik T., Cabane J., Dupuy A., et al. Impact of glucocorticoid-induced adverse events on adherence in patients receiving long-term systemic glucocorticoid therapy. Br J Dermatol 2010, 163:832-837.
10. Horne R., Weinman J., Hankins M. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999, 14:1-24.
11. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74.
12. Sewitch M.J., Abrahamowicz M., Barkun A., Bitton A., Wild G.E., Cohen A., et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003, 98:1535-1544.
13. Prado J.C., Kupek E., Mion D. Validity of four indirect methods to measure adherence in primary care hypertensives. J Hum Hypertens 2007, 21:579-584.
14. Fardet L., Petersen I., Nazareth I. Description des prescriptions de corticothérapies orales en population générale. Rev Med Interne 2011, 32:594-599.
15. Cullen G., Kelly E., Murray F.E. Patients' knowledge of adverse reactions to current medications. Br J Clin Pharmacol 2006, 62:232-236.
16. Morrison E., Crosbie D., Capell H.A. Attitude of rheumatoid arthritis patients to treatment with oral corticosteroids. Rheumatology (Oxford) 2003, 42:1247-1250.
17. Garcia Popa-Lisseanu M.G., Greisinger A., Richardson M., O'Malley K.J., Janssen N.M., Marcus D.M., et al. Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease. J Rheumatol 2005, 32:913-919.
18. Lin W.S., Yang W.S., Lin H.Y. Prednisolone non-compliance and its related factors in patients with systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi (Taipei) 1995, 56:244-251.
19. Chambers S., Raine R., Rahman A., Hagley K., De Ceulaer K., Isenberg D. Factors influencing adherence to medications in a group of patients with systemic lupus erythematosus in Jamaica. Lupus 2008, 17:761-769.
20. Shi L., Liu J., Koleva Y., Fonseca V., Kalsekar A., Pawaskar M. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics 2010, 28:1097-1107.
21. Ammassari A., Antinori A., Cozzi-Lepri A., Trotta M.P., Nasti G., Ridolfo A.L., et al. Relationship between HAART adherence and adipose tissue alterations. J Acquir Immune Defic Syndr 2002, 31:S140-S144.
22. Duran S., Spire B., Raffi F., Walter V., Bouhour D., Journot V., et al. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials 2001, 2:38-45.